Chris Bergstrom , MBA- President AmalgamRx

Chris is a pioneer in Digital Therapy (DTx) and recognized leader in Digital Health. Currently serving as President of AmalgamRx, a leader in building and commercializing DTx’s across the globe. Previously he was Partner and Head of Digital Therapy at the Boston Consulting Group (BCG) and served as Chief Commercial Officer of WellDoc, where they launched the world’s first FDA cleared, RCT proven, reimbursed DTx. Prior to digital, Chris held executive roles across Pharma, MedTech, and Diagnostics. He’s passionate about decentralizing and modernizing healthcare and has served as an investor / board advisor to various digital health innovators and government agencies. Chris holds two digital health patents and degrees from Indiana and Columbia University

What do you think?

Written by hsandm


Leave a Reply

Your email address will not be published. Required fields are marked *



Novartis Oncology Head: from Medicine to Management

How Teleflex Grew its Market Value 4x in 6 Years